Search Results - "Monte, Scott V."

Weight loss differences seen between glucagon-like peptide–1 receptor agonists and sodium–glucose cotransporter–2 inhibitors for treatment of type 2 diabetes by Frieling, Katherine, Monte, Scott V., Jacobs, David, Albanese, Nicole Paolini

“…Weight loss is an advantageous quality for diabetic medications because it can improve insulin sensitivity and glucose control and reduce cardiovascular risk…”
Get full text

Reduction in Opiate Use, Pain, Nausea, and Length of Stay After Implementation of a Bariatric Enhanced Recovery After Surgery Protocol by Monte, Scott V., Rafi, Ebne, Cantie, Shawn, Wohaibi, Eyad, Sanders, Christina, Scovazzo, Nicole C.

“…Purpose Evaluate adherence to bariatric surgery enhanced recovery after surgery (ERAS) protocols in pre-operative, operative, and post-operative phases, and to…”
Get full text

Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus by Monte, Scott V., PharmD, Caruana, Joseph A., MD, Ghanim, Husam, PhD, Sia, Chang Ling, BSc, Korzeniewski, Kelly, BSc, Schentag, Jerome J., PharmD, Dandona, Paresh, MD, PhD

“…Background Roux-en-Y gastric bypass (RYGB) results in profound weight loss and resolution of type 2 diabetes mellitus (T2DM). The mechanism of this remarkable…”
Get full text

Reduction in Inflammation and the Expression of Amyloid Precursor Protein and Other Proteins Related to Alzheimer's Disease following Gastric Bypass Surgery by Ghanim, Husam, Monte, Scott V, Sia, Chang Ling, Abuaysheh, Sanaa, Green, Kelly, Caruana, Joseph A, Dandona, Paresh

“…Objective: Obesity and type 2 diabetes are associated with an increase in the incidence and prevalence of Alzheimer's disease (AD) and an impaired cognitive…”
Get full text

Distal small bowel bypass for weight regain after gastric bypass: safety and efficacy threshold occurs at<70% bypass by Caruana, Joseph A., M.D, Monte, Scott V., Pharm.D, Jacobs, David M., Pharm.D, Voytovich, Catherine, Pharm.D, Ghanim, Husam, Ph.D, Dandona, Paresh, M.D., Ph.D

“…Abstract Background For patients with poor weight loss (WL) after Roux-en-Y gastric bypass (RYGB) there are few well-tolerated and effective surgical options…”
Get full text

Knowledge and Attitudes of Student Pharmacists Regarding Polypharmacy and Deprescribing: A Cross-Sectional Study by Clark, Collin M., Hejna, Mary, Shao, Elaine, Maerten-Rivera, Jaime L., Monte, Scott V., Wahler, Robert G.

“…Pharmacists play a key role in deprescribing medications. Incorporation of this concept into pharmacy school curricula is important in ensuring that graduates…”
Get full text

Obesity and Inflammation and Altered Clopidogrel Pharmacokinetics and Pharmacodynamics by Norgard, Nicholas B, Monte, Scott V

“…Clopidogrel is a key antiplatelet drug that has substantial interpatient variability in pharmacodynamic response. Patients with lesser degrees of platelet…”
Get more information

Impact of Sleeve Gastrectomy on Psychiatric Medication Use and Symptoms by Caruana, Joseph A., Mustafa, Esra, Russo, Kristen M., Monte, Scott V.

“…Background. Sleeve gastrectomy (SG) has become the primary bariatric surgery procedure in the U.S. Over 50% of people presenting for surgery have psychiatric…”
Get full text

Safety of ceftriaxone sodium at extremes of age by Monte, Scott V, Prescott, William Allan, Johnson, Kristin K, Kuhman, Lori, Paladino, Joseph A

“…Isolated reports of neonatal and infant deaths associated with ceftriaxone-calcium precipitation in the lungs and kidneys have prompted a recommendation from…”
Get more information

Reply: Real-world weight loss with diabetes medications: but is it actually real? by Albanese, Nicole Paolini, Jacobs, David, Frieling, Katherine, Monte, Scott V.

Get full text

Bariatric Surgery: Remission of Inflammation, Cardiometabolic Benefits, and Common Adverse Effects by Biobaku, Fatimo, Ghanim, Husam, Monte, Scott V, Caruana, Joseph A, Dandona, Paresh

“…Abstract Obesity is associated with increased mortality as a result of several comorbidities which occur in tandem with the obese state. Chronic inflammation…”
Get full text

A pharmacist-led pilot program to facilitate deprescribing in a primary care clinic by Clark, Collin M., LaValley, Susan A., Singh, Ranjit, Mustafa, Esra, Monte, Scott V., Wahler, Robert G.

“…To develop and pilot-test a model in which a community-based clinical pharmacist was incorporated as part of a Medicare Annual Wellness Visit (AWV) to make…”
Get full text

Increase in the mediators of asthma in obesity and obesity with type 2 diabetes: Reduction with weight loss by Dandona, Paresh, Ghanim, Husam, Monte, Scott V., Caruana, Joseph A., Green, Kelly, Abuaysheh, Sanaa, Lohano, Teekam, Schentag, Jerome, Dhindsa, Sandeep, Chaudhuri, Ajay

“…Objective To determine whether the expression of key asthma related genes, IL‐4, LIGHT, LTBR, MMP‐9, CCR‐2, and ADAM‐33 in mononuclear cells and the plasma…”
Get full text

Interventions to deprescribe potentially inappropriate medications in the elderly: Lost in translation? by Baumgartner, Andrew D., Clark, Collin M., LaValley, Susan A., Monte, Scott V., Wahler, Robert G., Singh, Ranjit

“…What is known and objective Use of potentially inappropriate medications (PIMs) remains common in older adults, despite the easy availability of screening…”
Get full text

Aspirin responsiveness changes in obese patients following bariatric surgery by Norgard, Nicholas B, Monte, Scott V, Fernandez, Stanley F, Ma, Qing

“…Bariatric surgery has emerged as a promising treatment option for weight loss and to counter the metabolic consequences of obesity. Obesity has been linked to…”
Get more information

Impact of Pharmacist Intervention on Clinical Outcomes in the Palliative Care Setting by Wilson, Shelley, Wahler, Robert, Brown, Jack, Doloresco, Fred, Monte, Scott V.

“…Background: Although accepted as an integral part of the interdisciplinary team, pharmacist value in palliative care has predominantly been evaluated by…”
Get full text

Provider Perception of Pharmacy Services in the Patient-Centered Medical Home by Albanese, Nicole P., Pignato, Alyssa M., Monte, Scott V.

“…Background: Despite the positive data on clinical outcomes, cost savings, and provider experience, no study has surveyed providers to evaluate what pharmacy…”
Get full text

Mo1566 A Neural Net Model for Pediatric and Adult NAFLD and NASH Using Health Records: Comparison With Type 2 Diabetes Patients and Predicted Beneficial Treatment of Both Components of Metabolic Syndrome With an Oral Mimetic of Roux-en-Y Gastric Bypass by Schentag, Jerome J, Stefanovic, Filip, Abdou, Reham M, Baker, Robert D, Fayad, Joseph M, Monte, Scott V, Jacobs, David M, Baker, Susan S

Get full text

Pharmacist home visits: A 1-year experience from a community pharmacy by Monte, Scott V, Passafiume, Sarah N, Kufel, Wesley D, Comerford, Patrick, Trzewieczynski, Dean P, Andrus, Kenneth, Brody, Peter M

“…Abstract Objective To provide experience on the methods and costs for delivering a large-scale community pharmacist home visit service. Setting Independent…”
Get full text

Opportunities and Recommendations for Improving Medication Safety: Understanding the Medication Management System in Primary Care Through an Abstraction Hierarchy by Baumgartner, Andrew, Kunkes, Taylor, Clark, Collin M, Brady, Laura A, Monte, Scott V, Singh, Ranjit, Wahler Jr, Robert G, Chen, Huei-Yen Winnie

“…Background Despite making great strides in improving the treatment of diseases, the minimization of unintended harm by medication therapy continues to be a…”
Get full text